Anthos Therapeutics Announces Appointment of Bill Meury as CEO
GlobeNewswire
CAMBRIDGE, Mass., April 22, 2024 (GLOBE NEWSWIRE) -- Anthos Therapeutics, Inc. (Anthos), is a clinical-stage company developing..
CAMBRIDGE, Mass., April 22, 2024 (GLOBE NEWSWIRE) -- Anthos Therapeutics, Inc. (Anthos), is a clinical-stage company developing..
The Tissue Engineered Skin Substitute market studied is anticipated to grow with a CAGR of nearly 3.9% during the forecast period...
The global regenerative medicine market is booming, driven by rising chronic diseases and advancements in cell therapies, gene..
Goodwin's Securities and Shareholder Litigation and White Collar Defense lawyers have extensive experience before US federal and..